微RNA-1912通过准PCSK9来调节胆固醇稳态
Chan Joo Lee1, Myeongjune Go2, Sae-Bom Jeon2
1Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, South Korea.
Molecular therapy. Nucleic acids
|July 17, 2025
概括
微RNA-1912 (miR-1912) 通过向PCSK9.9有效降低胆固醇. 这项研究验证了miR-1912作为高胆固醇血症的强效治疗剂,证明了其在动物模型中的有效性.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 蛋白转化酶亚素/素9型 (PCSK9) 通过促进低密度脂蛋白受体 (LDLR) 降解来调节胆固醇稳态.
- 以前对调节PCSK9的微RNA (miRNA) 的研究在动物模型中产生了有争议的结果.
研究的目的:
- 识别和验证调节PCSK9表达的微RNA候选物.
- 调查PCSK9调节中最强大的miRNA的治疗潜力in vivo.
主要方法:
- 生物信息分析以确定PCSK9.9的潜在miRNA标.
- 使用HepG2细胞进行体外研究,以评估miR-224和miR-1912对PCSK9和LDLR水平的影响.
- 路西法酶记者测定和位点定向突变发生,以确认miRNA-目标相互作用.
- 在体内对转基因小鼠进行研究,以评估miR-1912模仿剂对血胆固醇水平的影响.
主要成果:
- 生物信息分析发现miR-224和miR-1912是PCSK9.9的高概率调节者.
- miR-224和miR-1912都降低了PCSK9的mRNA和蛋白质水平,增加了HepG2细胞中的LDLR表达和LDL吸收,miR-1912显示出更强的效果.
- 证实了miR-1912和miR-224与PCSK9mRNA的3' UTR的直接相互作用.
- 转基因小鼠的miR-1912模拟的肝脏输送显著降低了血总胆固醇.
结论:
- miR-1912是PCSK9的强有力的调节剂,也是高胆固醇血症的有前途的治疗候选者.
- 通过miR-1912对PCSK9进行有针对性的后转录调节,为管理高胆固醇水平提供了一种新的策略.
相关概念视频
Cholesterol: Significance and Regulation
696
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
696
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
878
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
878
Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
Transducer Mechanism: Nuclear Receptors
1.7K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.7K


